News on books and Eli Lilly
ShareAnalyze the latest news on books and Eli Lilly, extract the entire dataset or get visualizations.
Related dashboards:
Latest news
Eli Lilly given US approval to treat sleep disorder with weight-loss drug
Healthy Returns: Eli Lilly's cholesterol pill impresses in mid-stage trial
Off-brand Ozempic, Roche stock woes, and Eli Lilly's weekly insulin: Pharma news round up
Eli Lilly's weekly insulin is running into the same issue Novo Nordisk's did
Eli Lilly's weight-loss drug cuts diabetes risk, long-term study finds
Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial
Eli Lilly Says Weight-Loss Drug Sharply Reduces Diabetes Progression
Eli Lilly's weight loss drug almost eliminates the risk of diabetes in overweight adults
Eli Lilly Says Weight-Loss Drug Sharply Reduces Diabetes Progression
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugs
FDA Advisory Panel Endorses Approval of Alzheimer's Drug Made by Eli Lilly
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
Eli Lilly says its experimental weekly insulin works just as well as daily doses
Eli Lilly lifts guidance on strong sales of diabetes and weight loss drugs
Weight loss drugs are still hard to find -- but Novo Nordisk and Eli Lilly are trying to change that
Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease
Extract data
Extract all the news on this scope:
Visualize data
Trend on this scope:
Evolution through time
Source analysis:
Distribution of sources in the news
Section analysis:
Distribution of sections in the news
Current sentiment polarity: slightly positive (0.62)
| positive | 71% | |
| neutral | 25% | |
| negative | 4% |
Sentiment polarity through time
